20 mg Tablet: Treatment of mild reflux disease and associated symptoms (eg, heartburn, acid regurgitation, pain on swallowing); long-term management and prevention of relapse in reflux esophagitis; prevention of gastroduodenal ulcers induced by nonselective, nonsteroidal anti-inflammatory drugs (NSAIDs), in patients at risk with a need for a continuous NSAID treatment.
40 mg Tablet: In combination with 2 appropriate antibiotics for the eradication of Helicobacter pylori in patients with peptic ulcers to reduce recurrence of duodenal and gastric ulcers caused by the microorganism; duodenal and gastric ulcers; moderate and severe cases of inflammation of the esophagus (reflux esophagitis); Zollinger-Ellison syndrome and other pathological hypersecretory conditions.